Semaglutide, GLP-1 Drugs, and IBS: Managing Side Effects and Gut Health

Supporting gut health while managing IBS and medications.

Glucagon-like peptide-1 (GLP-1) receptor agonist medications,  such as semaglutide (brand names Wegovy®, Ozempic®), have surged in popularity for weight loss and type 2 diabetes management. These drugs work by mimicking a gut hormone that slows digestion and reduces appetite, leading to significant weight loss in many patients. However, their effects on the digestive system raise important questions for people with Irritable Bowel Syndrome (IBS). IBS is a common functional gut disorder, affecting an estimated 10–15% of adults (especially women), and is characterized by chronic abdominal pain and changes in bowel habits.. Given that IBS symptoms can include diarrhoea, constipation, bloating, and pain, IBS patients are understandably concerned about how GLP-1 medications might influence their sensitive digestive systems.

In this post, we’ll explore how GLP-1 medications like semaglutide affect the gut, what the current research and real-world experience say about their impact on IBS symptoms, and practical strategies to manage IBS while on GLP-1 therapy. 

How GLP-1 Medications Affect Digestion

GLP-1 receptor agonists (GLP-1 RAs) such as semaglutide fundamentally alter GI function as part of their therapeutic effect. Semaglutide works by slowing gastric emptying, meaning food stays in the stomach longer, and by signaling fullness to the brain, which reduces appetite. This slowed digestive transit can have several downstream effects: it reduces the speed at which intestines move (peristalsis), and can modulate hormones and the gut-brain signals involved in nausea and satiety. In fact, GLP-1 RAs were studied for their effect on gut motility long before their rise as weight-loss drugs. For example, in clinical trials a GLP-1 analog (ROSE-010) “significantly retarded gastric emptying” in IBS patients, confirming that GLP-1 activity slows upper GI tract movement.

Because of these effects, gastrointestinal side effects are extremely common with GLP-1 medications. In trials of semaglutide for weight management, up to 44% of patients reported nausea and about 24% reported vomiting. Other frequent side effects include diarrhoea, constipation, abdominal pain, bloating, gas, and indigestion. These occur because GLP-1 receptors in the gut and brain are being activated, slowing digestion and sometimes causing gut hypersensitivity. On the bright side, most of these side effects are mild to moderate and tend to improve over time as your body adjusts to the medication. Nausea is usually worse at the beginning and often diminishes after a few weeks of dose stabilization. Manufacturers even advise starting at a low dose and titrating slowly (e.g. starting semaglutide at 0.25 mg weekly) to give the GI tract time to adapt. Nonetheless, the overlap between GLP-1 side effects and IBS symptoms means we need to look carefully at how these medications might exacerbate or alleviate IBS in different scenarios.

IBS 101: Symptoms, Subtypes, and Triggers

Living with IBS often means dealing with unexpected abdominal pain and discomfort in daily life.

Before diving deeper, let’s recap what IBS involves. IBS (Irritable Bowel Syndrome) is a chronic disorder of gut-brain interaction, defined by abdominal pain and altered bowel habits without any visible structural disease. It is typically classified into subtypes based on the predominant bowel habit:

• IBS-D (diarrhoea-predominant) - frequent loose/watery stools; urgency is common.

• IBS-C (constipation-predominant) - infrequent, hard stools and straining.

• IBS-M (mixed) – alternating diarrhoea and constipation episodes.

Many IBS patients also experience bloating, excess gas, and cramping, and symptoms often flare in response to triggers like certain foods or stress. IBS is a diagnosis of exclusion, meaning doctors rule out other diseases (like inflammatory bowel disease or coeliac disease), and it tends to follow a relapsing-remitting course. While not life-threatening, IBS can significantly impact quality of life and daily routines. Management typically centers on dietary modifications (for instance, many patients find relief with a low-FODMAP diet that reduces fermentable carbohydrates), stress reduction, and medications or supplements to target specific symptoms (e.g. fibre supplements for constipation, loperamide for diarrhoea, antispasmodics or peppermint oil for pain, etc.).

Importantly, IBS itself does not cause weight gain or loss inherently, but its symptoms can indirectly affect nutrition and lifestyle. Some IBS patients gain weight due to fear of exercise or limited diets, while others lose weight if symptoms curb their appetite. Meanwhile, obesity and IBS are common conditions that can co-exist, so it’s no surprise that with millions now using GLP-1 drugs for weight loss, many IBS sufferers find themselves navigating both issues simultaneously. This overlap sets the stage for the key question: How do GLP-1 medications (like semaglutide) interact with IBS symptoms?

How GLP-1 Medication Can Influence IBS Symptoms

The effect of a GLP-1 agonist on IBS can vary widely depending on the IBS subtype and individual response. Let’s break down some potential scenarios and what we know so far:

• If you have IBS-D (diarrhoea-predominant): Slowing down gastrointestinal transit could actually be beneficial in this case. GLP-1 drugs tend to delay gastric emptying and intestinal motility, which might reduce diarrhoea frequency and urgency. In theory, if food moves more slowly, the colon has more time to absorb water, potentially firming up stools. Some patients with IBS-D report fewer rush-to-the-bathroom moments after starting semaglutide, likely thanks to this effect. However, caution is warranted - GLP-1 agonists can also cause periodic loose stools or gastric upset (e.g. if nausea triggers vomiting or if certain foods aren’t tolerated well). So while many IBS-D folks might see an improvement in diarrhoea, a subset could experience unpredictable bowel movements, especially during the initial weeks of therapy. Every individual is different, so monitor closely how your IBS-D reacts.

• If you have IBS-C (constipation-predominant): This is where challenges can arise. Because GLP-1 slows gut motility, there’s a risk of worsened constipation in IBS-C. Indeed, some semaglutide users without IBS already report constipation as a side effect, and in an IBS-C patient who’s prone to sluggish bowels, the added delay can lead to harder, less frequent stools. Clinical research hints at a nuanced picture: interestingly, one trial with a GLP-1 analog (ROSE-010) noted that low doses actually accelerated colonic transit at 48 hours, possibly helping constipation, while higher doses mainly delayed stomach empty. This suggests there might be a sweet spot where GLP-1 agonists alleviate pain and bloating in IBS-C without significantly impairing bowel movements. In practice, though, many IBS-C patients on semaglutide need to be proactive with constipation-countering measures (more on strategies in the next section). If you have IBS-C, go in with eyes open: you may need to adjust your diet or medications to prevent a back-up.

• If you have IBS-M (mixed type): Those with alternating diarrhoea and constipation might experience a bit of both effects. Some IBS-M patients on GLP-1 therapy report that their diarrhoeal episodes became less frequent (a welcome change), but constipation phases became more pronounced. The net effect on overall comfort can vary, for example, if diarrhoea was the more troublesome symptom for you, semaglutide might feel like a net win despite some constipation, or vice versa. Notably, research suggests GLP-1 agonists may especially benefit IBS-M patients in terms of pain relief. In clinical trials of ROSE-010 for IBS, the greatest pain reductions were seen in IBS-M and IBS-C groups, implying that those with mixed symptoms can gain significant relief in abdominal pain and cramping from GLP-1 activation. However, careful management is needed to handle whichever bowel habit swing is amplified.

• IBS Pain and Bloating: One intriguing aspect is the effect of GLP-1 on the hallmark IBS symptom of abdominal pain (often due to gut spasm and visceral hypersensitivity). Remarkably, GLP-1 receptor agonists have shown promise in dampening IBS pain. A 2022 clinical study found that an injectable GLP-1 agonist given during IBS flare-ups significantly reduced pain intensity compared to placebo – twice as many patients achieved meaningful pain relief with the GLP-1 analog than with placebo. Pain relief kicked in quickly (within 1–2 hours of the injection) and was most effective in female patients and those with constipation- or mixed-type IBS. Researchers suspect GLP-1 may calm the gut’s nervous system and diminish visceral hypersensitivity, the heightened pain perception in IBS. Additionally, IBS patients with constipation have been found to have lower natural GLP-1 levels, and lower GLP-1 correlated with more pain,  suggesting a deficiency of GLP-1 signaling might be related to IBS symptoms. By restoring that signaling with a medication like semaglutide, it’s hypothesized we can relieve pain and possibly reduce bloating. In fact, some early studies and patient reports indicate bloating and abdominal discomfort improve on GLP-1 therapy, likely due to the slowed, more gradual digestive process. Essentially, the gut is not “rushing” contents through, which may reduce cramping and gas buildup for some people.

Of course, these benefits must be balanced against side effects. Higher doses of GLP-1 analogs can themselves cause GI distress (nausea, etc.), which in an IBS patient could trigger symptom flare-ups. The ROSE-010 trials, for example, noted that at higher doses patients had more nausea and some vomiting. And while semaglutide isn’t currently an established treatment for IBS on its own (doctors do not prescribe Ozempic/Wegovy for IBS per se), these findings are encouraging in highlighting GLP-1’s role in gut function. In real-world terms, some IBS patients will find that semaglutide helps their symptoms, especially bloating and post-meal discomfort, whereas others might feel it worsens their baseline IBS, largely depending on individual GI sensitivity and IBS subtype.

Key point: GLP-1 medications can be a two-faced coin for IBS. They may alleviate certain IBS problems (like urgency, pain, bloating) thanks to slower motility and gut-level effects. But they may also exacerbate issues (like constipation or periodic diarrhoea and nausea) due to the very same mechanisms. The outcome is highly individual. That’s why if you have IBS and are considering or already on a GLP-1 agonist, it’s crucial to be aware of these possibilities and have a plan to manage your symptoms.

Common GI Side Effects of GLP-1 Therapy (and Their Overlap with IBS)

Doctors discussing GLP-1 side effects and their overlap with IBS.

It bears repeating just how common gastrointestinal side effects are with GLP-1 agonists, and these side effects often mirror IBS symptoms. According to clinical trial data for semaglutide: nausea (up to 44% of patients) and diarrhoea (~30%) are the top complaints, followed by vomiting (~24%), constipation, and general stomach discomfort. Many patients also experience bloating, excessive gas (flatulence & belching), and heartburn. If you have IBS, you might read that list and think “well, that’s basically my life already.” Indeed, the overlap is significant. For someone whose IBS is usually well-controlled, starting a GLP-1 might introduce new or stronger GI symptoms that feel like an IBS flare. And for others, the drug’s effects might be hard to distinguish from IBS itself.

A few specific points of overlap and concern:

• Nausea and Appetite Loss: IBS itself can cause nausea in some cases (often related to pain or visceral sensitivity), but it’s not a dominant IBS symptom. On semaglutide, nausea can be pronounced, especially in the first 1–2 months. While this typically improves, persistent nausea can reduce food intake and potentially mess with your eating schedule. IBS patients need to avoid long periods of not eating (to prevent bile acid buildup or hunger-triggered motility which can cause pain), so managing GLP-1 nausea is important. Simple measures like eating bland, low-fat snacks (crackers, toast) and ginger tea can help, and prescription anti-emetics are an option if needed. Discuss with your doctor if nausea is severe.

  
  

• Diarrhoea: If you have IBS-D, you’re no stranger to diarrhoea. Paradoxically, GLP-1 agonists can cause diarrhoea as a side effect in some people despite generally slowing gut transit. This may be due to altered digestion of certain foods or an imbalance in how the intestine absorbs water under the influence of these drugs. In trials, diarrhoea was often transient, occurring in the early weeks. However, if you are very sensitive, even a short bout of medication-induced diarrhoea might trigger your IBS to act up (for example, causing a cascade of colon contractions). On the other hand, if GLP-1 therapy reduces your baseline IBS-D episodes long-term, you might judge that a few days of mild loose stools during dose titration is a price worth paying. Hydration is critical here, both IBS and GLP-1 side effects can deplete fluids, so drink plenty of water and electrolytes if you’re experiencing diarrhoea.

  
  

• Constipation: This is a major consideration for IBS-C patients on GLP-1, but even those with IBS-M or IBS-D should be aware of it. As noted, semaglutide often leads to harder stools or less frequent bowel movements because the gut is moving slower and perhaps absorbing more water from stool. The risk with IBS is that constipation can in turn heighten abdominal pain and bloating. It’s worth proactively counteracting constipation from day one (see strategies below), rather than waiting until you haven’t gone for a week. Increasing fibre gradually (and possibly adding a soluble fibre supplement like psyllium) plus staying well-hydrated can mitigate this. Some patients also use stool softeners or gentle laxatives with medical guidance if needed.

  
  

• Bloating and Gas: Feeling bloated or gassy is common in IBS due to fermentation of foods (especially high-FODMAP carbs) and dysregulated gut motility. GLP-1 RAs can also cause bloating and burping, partly from delayed stomach emptying (food sits and ferments longer in the gut) and perhaps changes in gut bacteria. There is some intriguing evidence that GLP-1 may actually reduce bloating in the long run by improving gut transit regularity and reducing intestinal inflammation. But initially, as the body adapts, you might notice excess gas and fullness. Managing your diet (avoiding carbonated drinks, chewing slowly to reduce swallowed air, and possibly limiting high-FODMAP foods that produce gas) can help during this adjustment phase.

The good news is that for most people, these side effects peak early and then decline. A Healthline review notes that while GI side effects are common, they “often lessen over time as your body adjusts to the medication”. Semaglutide’s prescribing info also emphasizes that nausea is usually transient and leads to discontinuation in only a minority of patients. So, patience is key, but so is proactive management. In the next section, we’ll cover evidence-backed strategies and real-world tips to help IBS patients get through the initial hurdles and improve their symptoms while on GLP-1 therapy.

If you’re unsure whether your symptoms are from IBS or a GLP-1 side effect, I created a free resource, the IBS Flare Fix Kit, that helps you identify common triggers and calm your digestive system fast. You can download it here.

Strategies for Managing IBS Symptoms While Using GLP-1

Managing GI side effects of GLP-1 therapy can help you return to feeling more at ease.

Successfully using a GLP-1 medication when you have IBS requires a comprehensive, proactive approach. You want to reap the benefits of weight loss or blood sugar control while keeping your IBS as quiescent as possible. Here are strategies, from medical guidance to practical lifestyle tweaks, to help improve IBS symptoms during GLP-1 treatment:

1. Start Low and Go Slow: Always follow your prescriber’s dosing instructions exactly. GLP-1 agonists like semaglutide are introduced at a very low dose (to minimize side effects) and gradually increased over weeks. Do not rush the escalation, giving your gut time to adjust at each step greatly reduces IBS-disruptive side effects. If you’re very sensitive, talk to your doctor; they might even extend the duration of the lower doses before upping to the next dose. Careful titration is your friend when balancing IBS with GLP-1 therapy.

2. Mindful Meal Habits: Adjust how and when you eat to accommodate a slower digestive pace.

• Eat smaller, frequent meals instead of a few large meals. Large meals can overwhelm your stomach when it’s emptying slowly, leading to distension and discomfort. Smaller portions spaced evenly can provide nutrition without triggering as much IBS pain or nausea.

• Don’t eat too close to bedtime. Lying down on a full stomach can worsen reflux and bloating, especially with delayed gastric emptying. Give yourself 2–3 hours after the last meal before lying flat.

• Chew thoroughly and eat slowly. This reduces gulping air (less belching and gas) and aids digestion. It also helps you tune in to fullness cues, which GLP-1 will amplify, you may feel full on much less food, which is an adjustment mentally.

• Identify and avoid trigger foods. This is standard for IBS management, but doubly important now. Foods that you know provoke your IBS (be it greasy food, spicy dishes, dairy, high-FODMAP items like garlic/onion, beans, etc.) should be minimized. Since GLP-1 meds can cause temporary digestive disruption,, you don’t want to throw known IBS triggers into the mix. Many doctors recommend IBS patients on GLP-1 consider a gentle version of the low-FODMAP diet during the early phase of treatment. This means avoiding poorly absorbed sugars that can ferment and cause gas (like certain fruits, sweeteners, wheat, and legumes). Once you’re stable, you can systematically reintroduce foods to test tolerance.

• Low-fat, bland choices during nausea flares. If nausea is hitting, stick to plain, easily digestible foods (toast, crackers, rice, bananas, soup). This isn’t forever – just while you feel queasy. Also, avoid very rich or fried foods, which can intensify nausea and reflux on a GLP-1.

  
  

3. Optimize Fibre and Fluid Intake: Balancing fibre is crucial, especially for IBS-C folks.

• If constipation is an issue, slowly increase your fibre intake. Emphasis on slowly, as a sudden jump in fibre can cause gas and cramping, which you want to avoid. Add an extra 2–3 grams of fibre per day each week. Focus on soluble fibre (oats, cooked veggies, chia, flax, psyllium supplement) which is generally gentler on IBS. Soluble fibre can help form soft, bulky stool that is easier to pass, relieving constipation without promoting diarrhoea.

• Consider fibre supplements if you can’t meet needs through diet. Products like psyllium (Metamucil) or methylcellulose can be helpful for both IBS-C (for constipation) and IBS-D (they can bind somewhat to loose stool). A healthcare provider can guide you on the type and dose.

• Stay well hydrated – this one can’t be emphasized enough. Fibre only helps if there’s enough water for it to absorb. Plus, if you have any bouts of diarrhoea, you’ll need to replenish fluids. Aim for at least 8 glasses of water a day (more if tolerated). If nausea makes plain water unpalatable, try electrolyte drinks, herbal teas, or even sucking on ice chips to keep fluids coming.

• If constipation persists despite fibre and water, ask your doctor about stool softeners or osmotic laxatives. A gentle osmotic like polyethylene glycol (PEG) can draw water into the bowel to keep things moving. Use these under medical advice, especially since overuse could swing you toward diarrhoea - it’s a delicate balance.

  
  

4. Manage Side Effects Proactively: Don’t wait for side effects to derail you; anticipate and mitigate them:

• Track your symptoms. Keep a daily log of your IBS symptoms and GLP-1 side effects. Note bowel movements (frequency/consistency), pain episodes, nausea severity, etc. This will help you and your provider discern patterns, for instance, if diarrhoea spikes on the day after your injection, you can plan around that. Or if constipation builds up by week 3, you’ll see it and can intervene sooner.

  
  

• Over-the-counter aids: Use OTC medications judiciously for symptom flares, with guidance from your doctor. For example, if you experience cramping and diarrhoea, having loperamide (Imodium) on hand to take occasionally can be a relief (though avoid overuse, especially if you swing to constipation). If you have a day of unbearable bloating and spasms, an antispasmodic like dicyclomine (Bentyl) or even peppermint oil capsules might ease the pain. For significant nausea, ask about anti-nausea meds (such as ondansetron) or try natural remedies like ginger. Always discuss with your healthcare provider before adding new meds, to ensure they fit your overall plan.

  
  

• Adjust injection timing (if needed): Some patients find the timing of their GLP-1 dose can influence side effects. For example, taking your weekly semaglutide injection on a Friday night might allow you to weather any weekend GI side effects at home rather than on a workday. There isn’t hard science on the “best” time, but it’s something you can experiment with (again, with doctor’s input) if side effects are impacting your schedule.

  
  

• Monitor for serious symptoms: While rare, GLP-1 agonists have been linked to more serious GI issues like pancreatitis or gallbladder problems in a small number of patients. Also, severe gastroparesis (delayed stomach emptying) can occur. In fact, semaglutide is not recommended for patients with severe gastroparesis. If you start having intense, persistent abdominal pain that isn’t typical of your IBS, or vomiting that won’t stop, or inability to keep fluids down, seek medical attention. It’s likely not IBS and needs prompt evaluation.

5. Lifestyle and Stress Management: Your gut is intricately connected to your lifestyle habits and stress levels. IBS is notorious for flaring during stress, so when you introduce a new medication regimen, it’s wise to double-down on self-care:

• Regular exercise: Engage in regular physical activity, as tolerated. Exercise can help stimulate bowel motility (especially helpful if constipation is an issue) and is a proven stress-reducer. Even daily walks or gentle yoga can support digestion.

  
  

• Stress reduction techniques: Since stress and anxiety can worsen IBS symptoms, try incorporating relaxation practices into your routine. Mindfulness meditation, deep breathing exercises, yoga, or even counseling/therapy can provide tools to manage stress. This can make a real difference in how your gut behaves day-to-day. Remember, starting a weight loss journey or new medication can itself be stressful, and managing that will help your IBS.

  
  

• Sleep and routine: Aim for adequate sleep and a consistent daily routine. The gut thrives on rhythm. Irregular sleep or meal times can disrupt the gut’s motility patterns. Try to eat meals around the same times each day and maintain a sleep schedule, to the extent life allows.

6. Work Closely With Your Healthcare Provider: Last but certainly not least, keep open lines of communication with your doctor or GI specialist:

• Personalised advice: Every IBS patient is unique. Your provider can help personalize the above strategies, for instance, guiding you on how much fibre to take, or whether to use an IBS-specific medication during the GLP-1 titration phase. They can also help you weigh the benefits vs. risks of continuing the GLP-1 if IBS symptoms become challenging.

  
  

• Monitoring: Schedule follow-ups to discuss how you’re feeling. If something isn’t working, say, constipation is unmanageable or nausea is too severe, your doctor might adjust the dose escalation, prescribe a concurrent medication, or in some cases consider an alternative weight management approach. Don’t tough it out in silence and be miserable; there are often solutions, but your healthcare team needs to know what you’re experiencing.

  
  

• Don’t self-medicate without consultation: It can be tempting to throw every supplement or remedy at the problem, but some things can interfere (for example, certain supplements might affect absorption of medications, or a laxative overuse might cause electrolyte imbalances). Always loop your doctor or dietitian in before making significant changes.

  
  

• When to pause or stop: If despite all efforts your IBS is in constant flare on the GLP-1, it’s okay to reassess the plan with your provider. For some, the side effects may outweigh the benefits. A medical professional can help determine if what you’re experiencing is typical adjustment or a sign that this medication isn’t right for you. Safety comes first.

  
  

By implementing these strategies, many IBS patients are able to successfully continue GLP-1 therapy and even see improvements in their IBS management. For example, one might find that with diet tweaks and fibre support, their IBS-C stays stable on semaglutide, allowing them to benefit from weight loss. Another person with IBS-D might happily note that their daily morning diarrhoea calms down thanks to the medication’s effects, as long as they avoid fatty meals that trigger nausea. The key is individualization: learn what works for your body.

These strategies can make a big difference, but it’s not always easy to know which ones are right for your IBS type. That’s exactly what I help my clients with inside my IBS Success Plan a step-by-step program that combines evidence-based nutrition with personalised support so you don’t have to guess.

Finding the Balance: Expert Insights and Final Thoughts

Using GLP-1 medications when you have IBS is indeed a balancing act, but it’s one that many are navigating successfully with informed care. Current research provides some reassurance that GLP-1 agonists are not inherently dangerous for those with IBS, and in fact may offer additional gut benefits like reduced pain and improved barrier function. As we’ve discussed, semaglutide and similar drugs can modulate gut motility in ways that sometimes align favourably with IBS (e.g. calming an overactive GI tract in IBS-D) and other times pose challenges (e.g. exacerbating constipation in IBS-C).

The side effects profile of GLP-1 RAs overlaps with IBS symptoms, but with proactive management these side effects are usually temporary and tolerable. Think of the first 1–2 months as an adjustment period where you and your gut are getting used to the new normal. During this time, lean on the strategies outlined: meticulous diet choices, hydration, maybe a fibre supplement, stress reduction, and close contact with your healthcare team. Real-world cases and clinical guidance show that such measures make a big difference in comfort levels for IBS patients on GLP-1 therapy.

It’s also worth noting the bigger picture: weight loss itself (if needed) can potentially benefit overall health and perhaps indirectly ease some IBS burden. For instance, obesity is linked to increased inflammation and possibly a less healthy gut microbiome; losing weight with semaglutide might help reverse those factors, theoretically contributing to IBS improvement over time. Many patients also find that as they lose weight, they become more active and confident in making diet changes, positive lifestyle shifts that can help IBS. Of course, weight loss injections are not a silver bullet for underlying IBS triggers like stress or food sensitivities. So, continuing to address those (with diet, therapy, etc.) in parallel is important.

In conclusion, GLP-1 medications like semaglutide can coexist with IBS, and with the right approach, patients can achieve their weight management goals without derailing their digestive health. As an expert in gastroenterology, I emphasize individualized care: what works for one IBS patient on semaglutide might not be right for another. Always listen to your body and keep your providers in the loop. The intersection of metabolic health and gut health is an evolving area, and ongoing research will hopefully shed more light on how best to help people with IBS navigate these new weight loss tools.

By staying informed (as you are by reading this!), practicing proactive symptom management, and working with your healthcare team, you can find the balance that lets you benefit from GLP-1 therapy while keeping IBS under good control. Both your waistline and your gut can be happier for it, and that’s a win-win for your overall well-being.

If you’re starting a GLP-1 medication like semaglutide and also live with IBS, you don’t need to struggle through side effects and flare-ups alone. My IBS Success Plan is a self-paced online course that gives you a clear roadmap to calm your gut, manage symptoms, and build confidence in your food choices. You’ll also get monthly live Q&A calls with an IBS dietitian (that’s me!) and access to a private community of people on the same journey.

It’s designed for busy professionals who want expert guidance but also need flexibility. You can learn at your own pace, get answers when you need them, and feel supported by others who “get it.”

If you're not ready to dive into a course IBS Flare Fix Kit is a great place to start. It’s a practical guide with dietitian-approved tips to calm flare-ups fast,   perfect to have on hand when your symptoms catch you off guard. Download it here ➝